BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 24911587)

  • 1. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
    Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
    Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
    J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
    Her J; Jeong YY; Chung IK
    FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
    Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
    Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons.
    Conz A; Musi CA; Russo L; Borsello T; Colnaghi L
    Eur J Histochem; 2021 Aug; 65(s1):. PubMed ID: 34459572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
    Gibbs-Seymour I; Oka Y; Rajendra E; Weinert BT; Passmore LA; Patel KJ; Olsen JV; Choudhary C; Bekker-Jensen S; Mailand N
    Mol Cell; 2015 Jan; 57(1):150-64. PubMed ID: 25557546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
    Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
    Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.
    Galanty Y; Belotserkovskaya R; Coates J; Polo S; Miller KM; Jackson SP
    Nature; 2009 Dec; 462(7275):935-9. PubMed ID: 20016603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
    Han MM; Hirakawa M; Yamauchi M; Matsuda N
    Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.